×
About 2,205 results

ALLMedicine™ Growth Hormone Deficiency Center

Research & Reviews  761 results

Genetic Causes of Growth Disorders
https://clinicaltrials.gov/ct2/show/NCT02311322

May 20th, 2022 - Children often present to pediatricians and pediatric endocrinologists because of abnormal body growth, including both childhood growth failure and, less commonly, overgrowth. Sometimes the cause is evident, for example, growth hormone deficiency ...

Psychiatric Disorders and Peer-Victimization in Children and Adolescents With Growth Ho...
https://doi.org/10.1177/00099228221096654
Clinical Pediatrics; Gizli Çoban Ö, Bedel A et. al.

May 19th, 2022 - In this study, we aimed to investigate psychiatric disorders, bullying/victimization, and quality of life in children and adolescents with idiopathic growth hormone deficiency (GHD). Sixty-one children and adolescents who were diagnosed as having ...

Growth hormone deficiency interferes with dynamic brain networks in short children.
https://doi.org/10.1016/j.psyneuen.2022.105786
Psychoneuroendocrinology Tang J, Xia Y et. al.

May 14th, 2022 - This study aimed to explore the disparities in dynamic brain networks between children with growth hormone deficiency (GHD) and idiopathic short stature (ISS, non-growth hormone deficiency). This study enrolled 65 children with GHD and 60 sex- and...

see more →

Guidelines  1 results

Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline for Pr...
https://doi.org/10.1227/NEU.0000000000001387
Neurosurgery Fleseriu M, Bodach ME et. al.

Sep 17th, 2016 - Nonfunctioning pituitary adenomas (NFPAs) are among the most common pituitary lesions and may present with hypopituitarism and/or hyperprolactinemia. To review the existing literature as it pertains to preoperative endocrine assessment in the work...

see more →

Drugs  14 results see all →

Clinicaltrials.gov  42 results

Genetic Causes of Growth Disorders
https://clinicaltrials.gov/ct2/show/NCT02311322

May 20th, 2022 - Children often present to pediatricians and pediatric endocrinologists because of abnormal body growth, including both childhood growth failure and, less commonly, overgrowth. Sometimes the cause is evident, for example, growth hormone deficiency ...

Incidence of cCPHD in Denmark - a National Observational Study
https://clinicaltrials.gov/ct2/show/NCT05334563

Apr 27th, 2022 - Background Congenital combined pituitary hormone deficiency (cCPHD) is defined as the partial or complete loss of more than one hormone secreted from the pituitary gland, caused by genetic or prenatal factors. Combined pituitary hormone deficiency...

Fluids Administration During Combined Clonidine-Arginine Growth Hormone Stimulation Test
https://clinicaltrials.gov/ct2/show/NCT04465565

Feb 22nd, 2022 - The diagnosis of Growth Hormone deficiency in childhood requires the performance of an artificial pharmacological stimulation tests. There are number of substances that increase the secretion of growth hormone, among them Clonidine and Arginine. O...

PK and PD Study of LUM-201 in Children With Growth Hormone Deficiency.
https://clinicaltrials.gov/ct2/show/NCT04806854

Jan 24th, 2022 - This trial will have a single screening visit to assess if subjects are eligible to start study therapy. Once subjects have completed screening, and if they are determined to be eligible, they will return to the clinic for a 12-hour pulsatility st...

A Phase 3 Trial of the Safety, Tolerability and Efficacy of TransCon hGH Weekly Versus Daily hGH in Children With Growth Hormone Deficiency (GHD)
https://clinicaltrials.gov/ct2/show/NCT02781727

Jan 4th, 2022 - A 52 week trial of TransCon hGH, a long-acting growth hormone product, versus human growth hormone therapy. TransCon hGH will be given once-a-week, human growth hormone (hGH) will be given daily. Approximately 150 prepubertal, hGH-treatment naïve ...

see more →

News  63 results

FDA Approves First Once-Weekly Growth Hormone for Children
https://www.medscape.com/viewarticle/958043

Sep 2nd, 2021 - The US Food and Drug Administration (FDA) has approved lonapegsomatropin (Skytrofa, Ascendis Pharma), the first weekly subcutaneous injectable growth hormone for children with growth hormone deficiency (GHD). The approval was based on the findings...

More Promising Tirzepatide Data; Continuous Glucose Monitoring Wins in Diabetes
https://www.medpagetoday.com/endocrinology/generalendocrinology/92929

Jun 6th, 2021 - The investigational dual GIP and GLP-1 receptor agonist tirzepatide significantly reduced HbA1c levels and induced weight loss in patients with type 2 diabetes compared with insulin glargine in the SURPASS-4 trial, Eli Lilly announced. A randomize...

Weight Gain Common in Childhood Brain Tumor Survivors
https://www.medscape.com/viewarticle/947349

Mar 12th, 2021 - Children who have been treated for brain tumors often experience significant weight gain, and new findings suggest that this could be a sign of hypothalamic-pituitary (HP) dysfunction. "We believe that endocrine surveillance should be initiated ea...

First-of-Its Kind Guideline on Lipid Monitoring in Endocrine Diseases
https://www.staging.medscape.com/viewarticle/940135

Nov 2nd, 2020 - Endocrine diseases of any type — not just diabetes — can represent a cardiovascular risk and patients with those disorders should be screened for high cholesterol, according to a new clinical practice guideline from the Endocrine Society. "The sim...

Diabetes, Alcohol and Hypertension; Probiotics Succeed for Kids With Obesity
https://www.medpagetoday.com/endocrinology/generalendocrinology/88571

Sep 11th, 2020 - For people with type 2 diabetes, drinking more than one alcoholic beverage per day was associated with an increased risk for high blood pressure. (Journal of the American Heart Association) The phase III LOGICS trial met its primary endpoint, demo...

see more →

Patient Education  1 results see all →